Acamprosate to Aztreonam -- Bacitracin to Butorphanol -- Capecitabine to Cycloserine -- Dabigatran to Dyphylline -- Edetate Calcium Disodium to Exenatide -- Famciclovir to Fosfomycin -- Gabapentin to Glyburide -- Hetastarch to Hydroxyurea -- Ibandronate to Itraconazole -- Kanamycin to Ketorolac -- Lacosamide to Lurasidone -- Magnesium Citrate to Mycophenolate Mofetil -- Nabumetone to Nor fl oxacin -- O fl oxacin to Oxcarbazep -- Paliperidone to Pyridostigmine -- Quinapril to Quinine -- Ramipril to Ruxolitinib -- Salsalate to Sunitinib -- Tadala fi l to Trospi -- Valacyclovir to Voriconazole -- Zalcitabine to Zonisamide
Summary
As the population of patients with acute or chronic kidney disease grows, healthcare professionals need a resource that optimizes drug effectiveness while minimizing potential toxicity. Renal Pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function. This up-to-date and evidence-based reference closes several identified knowledge gaps concerning medications eliminated by the kidneys. Conveniently listed alphabetically by generic drug name, each drug has its own face page featuring typical dosing ranges, alternative dosing adjustments by strata of renal function, specific dosing for dialysis and other dosing schemes. This work will satisfy the dosing information needs of busy physicians involved in pharmacotherapy for patients with kidney disease, as well as pharmacists, nurses and students
